 |
 |
Chromos Molecular Systems Inc. is a public Canadian biotechnology company leading the development of innovative therapies using a proprietary gene delivery and expression system for the production of therapeutic proteins and cell-mediated gene therapies in the treatment of disease.
Chromos is achieving this objective with a unique mammalian chromosome technology platform from which multiple product candidates can be developed. Chromos' technology, referred to as The ACE System, is a unique and powerful vehicle for carrying genes into cells. |
Target market
This platform technology is the foundation for a new rapid, highly efficient, and rational method for engineering high expressing cell lines for biopharmaceutical production. The ACE System provides advantages over existing technologies in enabling the production of proteins in cellular production systems. In particular, it has been designed to address two critical factors in protein manufacturing: increasing the yield of the product and reducing the time to develop a high expressing cell line.
The ACE System is a set of components that allows for the rapid, tractable engineering and selection of high expressing cell lines. It has been designed for the large scale economic production of human biopharmaceuticals, including monoclonal antibodies, vaccines, and other therapeutic proteins. |
|
|
